Abstract
Six and 12-month outcomes are reported on 79 mentally ill persons attending either a 4- or 8-session community-based smoking cessation group. Quit rates at post, 3-, 6-, and 12-month follow-ups were 16, 19, 16, and 19%, respectively, with no significant effect of program length. These success rates are comparable to outcomes reported following group-based treatment with mentally healthy smokers. The majority of quitters used nicotine replacement therapy. Psychotropic medication dosages did not vary over time in quitters or non-quitters. No reductions in smoking were observed among non-quitters. Quitting smoking had no untoward effects on symptoms of mental illness or general functioning.
References
Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., & Monti, P. M. (2003). The Tobacco Dependence Treatment Handbook. New York: Guilford Press.
Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D., & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155, 974–976.
American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
Brown, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502–508.
de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. [References]. Schizophrenia Research, 76, 135–157.
Derogatis, L. R., & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 130, 595–605.
Dubovsky, S. (2005). Benzodiazepine receptor agonists and antagonists. In B.J. Sadock, & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry, (Vol. 2, 8th ed., pp. 2789). Philadelphia: Lippincott Williams & Wilkins.
Dursun, S., & Kutcher, S. (1999). Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research. Medical Hypotheses, 52, 101–109.
el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2001). Smoking cessation for individuals with mental illness or addictions. Psychiatric Services, 53, 1166–1170.
el-Guebaly, N., & Hodgins, D. (1992). Schizophrenia and substance abuse: Prevalence issues. Canadian Journal of Psychiatry, 37, 704–710.
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation schizophrenia. Nicotine & Tobacco Research, 3, 397–403.
Evins, A. E., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., & Goff, D. C. (2004). Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65, 307–311.
George, T., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.
George, T., Ziedonis, D., Feingold, A., Pepper, W., Satterburg, C., Winkel, J., & Kosten, T. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.
Heatherton, T. F., Kozlowski, L., Frecker, R. C., & Fragerstrom, K. (1991). The Fagerstrom test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119–1127.
Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling? Psychiatry, 160, 2228–2230.
Larsen, D., Attkinsson, C., Hargreaves, W., & Nguyen, T. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2, 197–207.
Lasser, K., Boyd, W., Woolhandler, S., Himmelstein, D., McCormick, D., & Bor, D. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284, 2606–2610.
Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., & Freedman, R. (2000). Smoking and schizophrenia: Abnormal nicotinic receptor expression. European Journal of Pharmacology, 393, 237–242.
MacKay, B. (2004). Butting out in Canada: Five down, eight to go. Canadian Medical Association Journal, 171, 558.
McChargue, D. E., Gulliver, S. B., & Hitsman, B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment. Addiction, 97, 785–793.
Moll, S., Goldberg, J., Washington, A., & Pawlick, J. (1996). Smoking and people with mental health problems: A how-to guide for support people. Hamilton, ON: CSVR Foundation.
Niaura, R., & Abrams, D. (2002). Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology, 70, 494–509.
Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723–728.
Thorndike, A. N., Stafford, R. S., & Rigotti, N. A. (2001). US physicians’ treatment of smoking in outpatients with psychiatric diagnoses. Nicotine and Tobacco Research, 3, 85–91.
Ventura, J., Lukoff, D., Nuechteriein, K., Liberman, R. P., Green, M. F., & Shaner, A. (1993). Manual for the expanded brief psychiatric rating scale (BPRS). International Journal of Methods in Psychiatric Research, 22, 1–20.
Williams, J. M., & Hughes, J. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 33, 457–466.
Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067–1083.
Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55, 1064–1066.
Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45, 204–206.
Acknowledgments
This project was funded by an Alberta Alcohol and Drug Abuse Commission (Edmonton, AB, Canada) Tobacco Reduction Phase I grant. Each author has contributed significantly to the work and agrees on this submission.
Author information
Authors and Affiliations
Corresponding author
Additional information
Portions of this paper were presented at: Currie, S., Karltyn, J., Lussier, D., Brown, D., and el-Guebaly, N. (2005, September). Smoking cessation program for persons with severe and persistent mental illness. Presentation at Global Perspectives on Chronic Disease Management: The Calgary Conference, Calgary, AB.
Currie, S., Lussier, D., Karltyn, J., el-Guebaly, N., Brown, D., and Goodale, L. (2004, November). A community-based smoking cessation program for persons with chronic mental illness. Presented at the 38th Annual Meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA.
Rights and permissions
About this article
Cite this article
Currie, S.R., Karltyn, J., Lussier, D. et al. Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness. Community Ment Health J 44, 187–194 (2008). https://doi.org/10.1007/s10597-007-9113-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-007-9113-8